Skip to main content

Table 3 Study inclusion and exclusion criteria

From: Renal Athersosclerotic reVascularization Evaluation (RAVE Study): Study protocol of a randomized trial [NCT00127738]

Inclusion criteria:
   • age 55 and older.
   • systolic blood pressure > 140 mmHg and/or diastolic > 90 mmHg despite at least 3 antihypertensive medications.
   • systolic blood pressure > 140 mmHg and/or diastolic > 90 mmHg on two antihypertensives with; a rise in creatinine > 20% after initiation of an ACEi or ARB
   • the sudden onset of hypertension occurring after age 55
   • hypokalemia
   • the presence of an abdominal bruit
   • history of flash pulmonary edema,
   • three of; Peripheral vascular disease, coronary artery disease, cerebrovascular disease, smoking, hyperlipidemia, diabetes or male gender.
Exclusion Criteria:
   • serum creatinine > 220 umol/L or estimated GFR by Cockroft Gault equation < 20 ml/min.
   • patients who are unwilling or unable to give informed consent.
   • Known contraindication to renal revascularization such as anaphylactic allergy to contrast dye
   • an abdominal aortic aneurysm requiring surgery
   • a single functioning kidney
   • a total occlusion of the renal artery
   • renal artery stenosis due to fibromuscular dysplasia
   • previous revascularization.